TY - JOUR AU - von Minckwitz, G; Procter, M; de Azambuja, E TI - Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer JO - N Engl J Med VL - 377 PY - 2017 DO - 10.1056/NEJMoa1703643 L3 - PubMed-ID: 28581356 SP - 122 EP - 131 N1 - et al. ER -